文献速递外周动脉疾病慢性静脉疾病

血栓弹力图指导下的深静脉动脉化抗凝评估:一项前瞻性分析

TEG-Guided Anticoagulation Assessment in Deep Vein Arterialization: A Prospective Analysis.
PubMed 文献 · Ann Vasc Surg · 2024-12-27

本研究对16例接受深静脉动脉化的外周动脉疾病患者(年龄>60岁)在基线、1、3、6个月行血栓弹力图及血小板图检测,评估不同术后血栓预防方案对凝血指标的影响。结果显示双联抗血小板治疗联合直接口服抗凝药组血小板抑制持续更优、ADP最大振幅最低,单联抗血小板治疗组血凝块强化最慢,提示凝血监测的重要性。

要点

  • 双联抗血小板治疗联合直接口服抗凝药组各时间点ADP最大振幅均低于其他组
  • 单联抗血小板治疗组枸橼酸化高岭土角度最小(65.25°),血凝块强化最慢
  • 深静脉动脉化尚无标准化血栓预防方案,术后用药由术者决定

核心结论

  • 血栓弹力图联合血小板图显示,双联抗血小板治疗联合直接口服抗凝药组血小板抑制增强、血凝块形成减少,提示凝血监测的重要性。

研究设计与样本

  • 前瞻性研究,2020—2024年纳入年龄>60岁、接受深静脉动脉化的外周动脉疾病患者16例,于基线、1、3、6个月行血栓弹力图评估,采用描述性统计分析凝血指标。

主要发现

  • 双联抗血小板治疗联合直接口服抗凝药组ADP最大振幅在基线为35.65 mm,其他组为42.2–65.03 mm;1个月为26.7 mm,其他组为32.14–69.4 mm;3个月为27.36 mm,其他组为32.2–39.97 mm;6个月为43.7 mm,其他组为50.2–50.5 mm,该组各时间点均为最低。
  • 单联抗血小板治疗组枸橼酸化高岭土角度为65.25°,其他组为68.7–71.55°,该组血凝块强化最慢。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Deep vein arterialization (DVA) is an innovative surgical technique aimed at enhancing blood flow in compromised limbs facing amputation. Maintenance of flow postrevascularization is crucial to limb salvage. As this is a new technique, no standardized thromboprophylaxis regime is currently established, and postprocedure thromboprophylaxis is at the discretion of the proceduralist. This study aims to evaluate coagulation profiles using viscoelastic studies in peripheral artery disease patients who underwent DVA, assessing the impact of various postprocedure thromboprophylaxis regimens. METHODS: Patients (aged > 60 years) undergoing DVA were prospectively evaluated using thromboelastography at baseline, 1, 3, and 6 months (2020-2024). Postprocedure thromboprophylaxis included mono antiplatelet therapy (MAPT), MAPT + direct oral anticoagulant (DOAC), dual antiplatelet therapy (DAPT), or DAPT + DOAC. Coagulation profiles were analyzed using descriptive statistics. RESULTS: Among 16 patients (mean age 66.6 years, 75% male/Caucasian), hypertension and hyperlipidemia were present in 91%, and diabetes in 88%. The DAPT + DOAC group showed consistently superior platelet inhibition with the lowest adenosine diphosphate maximum amplitude values throughout baseline (35.65 mm vs. 42.2-65.03 mm in other groups), 1 month (26.7 mm vs. 32.14-69.4 mm), 3 months (27.36 mm vs. 32.2-39.97 mm), and 6 months (43.7 mm vs. 50.2-50.5 mm). MAPT demonstrated the slowest clot strengthening (citrated kaolin angle 65.25° vs. 68.7-71.55°). CONCLUSION: Thromboelastography with platelet mapping demonstrated enhanced platelet inhibition and reduced clot formation in the DAPT + DOAC group, suggesting the importance of coagulation monitoring.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Cieri IF, Rodriguez Alvarez AA, Patel S, et al. TEG-Guided Anticoagulation Assessment in Deep Vein Arterialization: A Prospective Analysis. Ann Vasc Surg. 2024. PMID: 39733999. doi:10.1016/j.avsg.2024.12.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。